An enhanced antitumor immune response was associated with this phenomenon, as evidenced by increased lymphocyte infiltration and decreased immunosuppressive medullary cell infiltration in RIPK3-deficient pancreatic ductal carcinoma [6]. This evidence concerns the gene RIPK3 and pancreatic ductal adenocarcinoma.